FDA sets PDUFA Action Date of June 28, 2025 ...
GlobalData on MSN3d
Sonnet BioTherapeutics secures US patent covering two drug candidatesIL-18 plays a key role in regulating innate immune responses, affecting natural killer cells, monocytes and other cell types.
Hospital Authority says doctors will no longer need to go through two-tier assessment and can apply directly to introduce new drugs from mid-November Hongkongers will have quicker and cheaper access ...
Henlius and Organon announced US FDA has accepted the Biologics License Application (BLA) for HLX14, biosimilar candidate of ...
Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for donidalorsen, an investigational ...
A newly-approved chemical is now available to stop the spread of E. Coli, Salmonella and other infectious germs during ...
High Content Screening MarketThe global high content screening (HCS) market is set to experience impressive growth, with its market value expected to soar beyond USD 3 billion by 2033, up from over ...
Former President Donald Trump has boasted in recent months about “Right To Try,” a law he signed in 2018. It’s aimed at ...
Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that the Company has resubmitted its Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA or Agency) for ...
Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics focusing on oncology and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback